Longevity

NAD+ Injections vs IV vs Oral: The Evidence

NAD+ injections, IV drips and oral precursors (NR, NMN) compared: what human studies measured, FDA status of compounded NAD+, the food-grade NAD+ warning and safety.

Direct answer

No NAD+ injection or IV product is FDA-approved; prescription NAD+ is compounded under an FDA interim policy. Human data are thin: a small IV pilot found NAD+ disappeared from the blood for the first 2 hours of infusion, and we found no randomized trials showing that NAD+ injections improve aging or energy outcomes. Oral precursors (NR, NMN) have more randomized data, mainly showing they raise NAD+ levels. The FDA has warned about compounders using food-grade NAD+ for IV products.

NAD+ injections online: providers and cost →Telehealth providers compared side by side →Telehealth clinics that prescribe peptides →

· 8 min read ·

⚕️ Medical Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice. Consult a qualified healthcare provider before using any peptide.

What NAD+ is

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme every cell uses for energy metabolism and for enzymes involved in DNA repair and cell signaling. Animal studies link falling NAD+ to aging, which drove interest in raising it, either directly with NAD+ or with oral precursors such as nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) (Rajman et al., Cell Metab 2018, PMID: 29514064).

Most of that evidence comes from animals. In people, studies mostly measure whether NAD+ levels go up, not whether health outcomes improve.

This article is general information, not medical advice or a dosing recommendation. Decisions about starting, changing or stopping a prescription belong with a licensed clinician who knows your history.

Routes compared

RouteRegulatory statusWhat human studies show
IV infusionCompounded; no FDA-approved NAD+ drugSmall pilot: plasma NAD+ did not rise for the first 2 hours of a 6-hour infusion
Injection (subcutaneous or intramuscular)Compounded; no FDA-approved NAD+ drugNo randomized outcome trials found
Nasal sprayCompoundedNo randomized outcome trials found
Oral NR or NMNSold as dietary supplementsRandomized trials show raised NAD+ levels; outcome effects limited

IV. In a pilot study of a 6-hour NAD+ infusion, NAD+ was rapidly and completely removed from the blood for at least the first 2 hours; breakdown products appeared later and NAD+ itself showed up in urine (Grant et al., Front Aging Neurosci 2019, PMID: 31572171).

Injections and nasal sprays. We found no randomized controlled trials showing that NAD+ injections or sprays improve energy, cognition or aging outcomes.

Oral precursors. In a 6-week crossover trial in healthy middle-aged and older adults, NR was well tolerated and raised NAD+ metabolism (Martens et al., Nat Commun 2018, PMID: 29599478). In a 10-week trial in women with prediabetes and overweight or obesity, NMN increased muscle insulin sensitivity (Yoshino et al., Science 2021, PMID: 33888596). These are small, short studies, and supplements are not intended to diagnose, treat, cure or prevent any disease. Our NMN vs NR vs NAD+ guide compares them in detail.

FDA status of compounded NAD+

No FDA-approved drug contains NAD+ as an injection or infusion. Pharmacies compound it under section 503A, where NAD appears in Category 1 (“under evaluation”) of the FDA’s list of nominated bulk substances, updated May 14, 2026. In Category 1, the FDA does not intend to take action against compounders who meet the conditions of its interim policy; that is not an approval (FDA).

The FDA has also warned compounders that food-grade NAD+ sold by repackagers has been used to make IV products, that food-grade ingredients carry a high risk of microbial and endotoxin contamination, and that it has received adverse event reports after NAD+ injectables, including severe chills, shaking, vomiting and fatigue, some needing medical treatment (FDA).

Safety: questions to ask before NAD+ therapy

• Which licensed pharmacy compounds it, and can the provider name it?

• Is the NAD+ pharmaceutical grade (not food or supplement grade)?

• Who reviews your history before prescribing, and what should you do if you have a reaction?

Report fever, chills, shaking, vomiting or injection-site problems to the prescriber, and report adverse events to FDA MedWatch. People who are pregnant, breastfeeding or being treated for cancer should discuss NAD+ products with their own clinician, since they have not been studied in those groups.

This article is general information, not medical advice or a dosing recommendation. Decisions about starting, changing or stopping a prescription belong with a licensed clinician who knows your history.

Cost and online options

Current prices for prescription NAD+ injections and sprays are on NAD+ injections online. Approved partners that list NAD+ include HealthRX and Luvo Health; see our HealthRX review, Luvo Health review and the telehealth comparison hub.

Disclosure

CalcMyPeptide may earn commissions from some telehealth providers on our comparison and review pages, which list only vetted providers whose affiliate programs have approved us or are reviewing our application. This article contains no paid links. How we rank providers and get paid: telehealth disclosure and methodology.

❓ Frequently Asked Questions

Are NAD+ injections FDA-approved?▼
No. No NAD+ injection or infusion is FDA-approved. Pharmacies compound it under an FDA interim policy (Category 1, under evaluation, as of May 14, 2026), which is not an approval.
Are NAD+ injections better than oral NR or NMN?▼
There is no head-to-head evidence. Oral precursors have small randomized trials showing they raise NAD+ levels; we found no randomized trials showing NAD+ injections improve health outcomes.
What did the NAD+ IV study find?▼
In a pilot of a 6-hour NAD+ infusion, NAD+ was rapidly removed from the blood for at least the first 2 hours before levels and breakdown products rose, and some NAD+ was excreted in urine.
Why did the FDA warn about NAD+?▼
The FDA said some compounders used food-grade NAD+ to make IV products, which risks microbial and endotoxin contamination, and it received reports of severe chills, shaking, vomiting and fatigue after NAD+ injectables.

📖 References

  1. Rajman L, Chwalek K, Sinclair DA “Therapeutic potential of NAD-boosting molecules: the in vivo evidence.” Cell Metab (2018). PMID: 29514064
  2. Grant R, et al. “A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+.” Front Aging Neurosci (2019). PMID: 31572171
  3. Martens CR, et al. “Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults.” Nat Commun (2018). PMID: 29599478
  4. Yoshino M, et al. “Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.” Science (2021). PMID: 33888596
  5. U.S. Food and Drug Administration “Bulk drug substances nominated for use in compounding under section 503A (updated May 14, 2026).” FDA (2026). Source
  6. U.S. Food and Drug Administration “FDA reminds compounders to use ingredients suitable for sterile compounding (food-grade NAD+).” FDA human drug compounding (2024). Source

Featured in clinical protocols

Related articles

Share this article

Found this useful? Let others know too.